Jim Simons Burning Rock Biotech LTD Transaction History

Renaissance Technologies LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$0.68 - $0.97 $1,768 - $2,522	-2,600 Reduced 0.75%	342,700 $250,000
Q4 2023 Feb 13, 2024	SELL	$0.72 - $1.13 $4,824 - $7,570	-6,700 Reduced 1.9%	345,300 $321,000
Q3 2023 Nov 14, 2023	SELL	$0.91 - $2.29 $3,731 - $9,389	-4,100 Reduced 1.15%	352,000 $341,000
Q2 2023 Aug 11, 2023	SELL	$2.15 - $3.16 $14,620 - $21,488	-6,800 Reduced 1.87%	356,100 $766,000
Q1 2023 May 12, 2023	SELL	$2.16 - $3.47 $35,856 - $57,602	-16,600 Reduced 4.37%	362,900 $1.02 Million
Q4 2022 Feb 13, 2023	SELL	$1.73 - $2.95 $279,049 - $475,835	-161,300 Reduced 29.83%	379,500 $854,000
Q3 2022 Nov 14, 2022	SELL	$2.39 - $3.96 $1.33 Million - $2.21 Million	-557,400 Reduced 50.76%	540,800 $1.29 Million
Q2 2022 Aug 12, 2022	BUY	$1.75 - $10.44 $1.72 Million - $10.3 Million	984,600 Added 866.73%	1,098,200 $3.2 Million
Q1 2022 May 13, 2022	SELL	$6.7 - $10.23 $347,006 - $529,832	-51,792 Reduced 31.31%	113,600 $1.06 Million
Q4 2021 Feb 11, 2022	BUY	$9.43 - $17.14 $1.46 Million - $2.66 Million	155,292 Added 1537.54%	165,392 $1.58 Million
Q3 2021 Nov 12, 2021	BUY	$17.37 - $27.92 $175,437 - $281,992	10,100 New	10,100 $181,000

22.1K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $494M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.